New app aims to ease anxiety and depression in breast cancer survivors

NCT ID NCT07169539

Not yet recruiting Symptom relief Sponsor: Hospital Costa del Sol Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will test SerenApp, a smartphone app designed with input from patients and doctors to help breast cancer survivors cope with anxiety, depression, and stress. 90 women who have finished primary treatment will use the app for 8 weeks. Researchers will measure changes in emotional well-being and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SerenApp digital psychological intervention (smartphone app)
What this could lead to: If it works, this could provide a convenient, low-cost way for breast cancer survivors to manage emotional distress and improve quality of life.
What could go wrong: This is a small pilot study (90 participants) testing a new app, so results may not apply broadly. The app is self-guided and may not help everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Hospital Universitario Costa del Sol

Marbella, Malaga, 29603, Spain
Servicio Canario de la Salud

Santa Cruz de Tenerife, 38001, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.